This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2017 Aug 1;28(8):1694-1696.

doi: 10.1093/annonc/mdx135.

Cancer drug costs-the case for a thoughtful discussion of a manageable problem

K Dhingra¹

Affiliations

PMID: 28368452
DOI: 10.1093/annonc/mdx135

Free article

Editorial

Cancer drug costs-the case for a thoughtful discussion of a manageable problem

K Dhingra. Ann Oncol. 2017.

Free article

. 2017 Aug 1;28(8):1694-1696.

doi: 10.1093/annonc/mdx135.

Author

K Dhingra¹

Affiliation

¹ KAPital Consulting LLC, Sparta, USA.

PMID: 28368452
DOI: 10.1093/annonc/mdx135

No abstract available

PubMed Disclaimer

Comment on

Do patient access schemes for high-cost cancer drugs deliver value to society?-lessons from the NHS Cancer Drugs Fund.
Aggarwal A, Fojo T, Chamberlain C, Davis C, Sullivan R. Aggarwal A, et al. Ann Oncol. 2017 Aug 1;28(8):1738-1750. doi: 10.1093/annonc/mdx110. Ann Oncol. 2017. PMID: 28453615 Free PMC article. Review.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Other Literature Sources
- scite Smart Citations